• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带抗原的纳米颗粒的疫苗接种途径依赖性佐剂效应可增强疫苗效力。

Vaccination-Route-Dependent Adjuvanticity of Antigen-Carrying Nanoparticles for Enhanced Vaccine Efficacy.

作者信息

Song Chaojun, Hu Jinwei, Liu Yutao, Tian Yi, Zhu Yupu, Xi Jiayue, Cui Minxuan, Wang Xiaolei, Zhang Bao-Zhong, Fan Li, Li Quan

机构信息

School of Life Science, Northwestern Polytechnical University, 127th Youyi West Road, Xi'an 710072, China.

Department of Pharmaceutical Chemistry and Analysis, School of Pharmacy, Airforce Medical University, 169th Changle West Road, Xi'an 710032, China.

出版信息

Vaccines (Basel). 2024 Jan 26;12(2):125. doi: 10.3390/vaccines12020125.

DOI:10.3390/vaccines12020125
PMID:38400110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10892493/
Abstract

Vaccination-route-dependent adjuvanticity was identified as being associated with the specific features of antigen-carrying nanoparticles (NPs) in the present work. Here, we demonstrated that the mechanical properties and the decomposability of NP adjuvants play key roles in determining the antigen accessibility and thus the overall vaccine efficacy in the immune system when different vaccination routes were employed. We showed that soft nano-vaccines were associated with more efficient antigen uptake when administering subcutaneous (S.C.) vaccination, while the slow decomposition of hard nano-vaccines promoted antigen uptake when intravenous (I.V.) vaccination was employed. In comparison to the clinically used aluminum (Alum) adjuvant, the NP adjuvants were found to stimulate both humoral and cellular immune responses efficiently, irrespective of the vaccination route. For vaccination via S.C. and I.V. alike, the NP-based vaccines show excellent protection for mice from () infection, and their survival rates are 100% after lethal challenge, being much superior to the clinically used Alum adjuvant.

摘要

在本研究中,疫苗接种途径依赖性佐剂效应被确定与携带抗原的纳米颗粒(NP)的特定特征有关。在此,我们证明了NP佐剂的机械性能和可分解性在采用不同接种途径时,对于决定抗原可及性以及进而决定免疫系统中的整体疫苗效力起着关键作用。我们表明,在进行皮下(S.C.)接种时,软纳米疫苗与更高效的抗原摄取相关,而在采用静脉内(I.V.)接种时,硬纳米疫苗的缓慢分解促进了抗原摄取。与临床使用的铝(明矾)佐剂相比,发现NP佐剂无论接种途径如何,均能有效刺激体液免疫和细胞免疫反应。对于皮下和静脉内接种而言,基于NP的疫苗对小鼠免受()感染均显示出优异的保护作用,在致死性攻击后它们的存活率为100%,远优于临床使用的明矾佐剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/edfe0bdc26ba/vaccines-12-00125-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/749901adc689/vaccines-12-00125-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/80e08127d737/vaccines-12-00125-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/cfdc543c41d3/vaccines-12-00125-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/350964a51297/vaccines-12-00125-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/631b3ae9887f/vaccines-12-00125-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/17b357585aac/vaccines-12-00125-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/edfe0bdc26ba/vaccines-12-00125-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/749901adc689/vaccines-12-00125-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/80e08127d737/vaccines-12-00125-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/cfdc543c41d3/vaccines-12-00125-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/350964a51297/vaccines-12-00125-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/631b3ae9887f/vaccines-12-00125-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/17b357585aac/vaccines-12-00125-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2724/10892493/edfe0bdc26ba/vaccines-12-00125-g007.jpg

相似文献

1
Vaccination-Route-Dependent Adjuvanticity of Antigen-Carrying Nanoparticles for Enhanced Vaccine Efficacy.携带抗原的纳米颗粒的疫苗接种途径依赖性佐剂效应可增强疫苗效力。
Vaccines (Basel). 2024 Jan 26;12(2):125. doi: 10.3390/vaccines12020125.
2
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.用包裹在纳米颗粒中的Toll样受体配体辅助猿猴免疫缺陷病毒疫苗可诱导持续性抗体反应并增强对TRIM5α限制型猕猴的保护。
J Virol. 2017 Jan 31;91(4). doi: 10.1128/JVI.01844-16. Print 2017 Feb 15.
3
Aluminum-based metal-organic framework nanoparticles as pulmonary vaccine adjuvants.铝基金属有机骨架纳米粒子作为肺部疫苗佐剂。
J Nanobiotechnology. 2023 Feb 3;21(1):39. doi: 10.1186/s12951-023-01782-w.
4
Engineering aluminum hydroxyphosphate nanoparticles with well-controlled surface property to enhance humoral immune responses as vaccine adjuvants.用具有良好控制表面性能的工程化铝羟磷灰石纳米颗粒作为疫苗佐剂增强体液免疫反应。
Biomaterials. 2021 Aug;275:120960. doi: 10.1016/j.biomaterials.2021.120960. Epub 2021 Jun 7.
5
Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.重组P二聚体疫苗诱导的诺如病毒(NoV)特异性保护性免疫反应可被黏膜佐剂FlaB增强。
J Transl Med. 2016 May 17;14(1):135. doi: 10.1186/s12967-016-0899-4.
6
Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.聚阳离子修饰的聚乳酸微球通过常用的肠胃外给药途径诱导强烈的免疫反应。
Int Immunopharmacol. 2014 Dec;23(2):592-602. doi: 10.1016/j.intimp.2014.10.010.
7
Nano alum: A new solution to the new challenge.纳米氧化铝:应对新挑战的新方案。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2060667. doi: 10.1080/21645515.2022.2060667. Epub 2022 Apr 26.
8
Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis.聚乳酸微球与明矾作为H5N1流感裂解疫苗佐剂的比较:佐剂活性评估及初步作用模式分析
Pharm Res. 2014 Apr;31(4):1015-31. doi: 10.1007/s11095-013-1224-z. Epub 2013 Oct 30.
9
The cationic lipid, diC14 amidine, extends the adjuvant properties of aluminum salts through a TLR-4- and caspase-1-independent mechanism.阳离子脂质体二 C14 脒通过 TLR-4 和 caspase-1 非依赖机制延长了铝盐的佐剂特性。
Vaccine. 2012 Jan 5;30(2):414-24. doi: 10.1016/j.vaccine.2011.10.071. Epub 2011 Nov 7.
10
Adjuvanticity and toxicity of cobalt oxide nanoparticles as an alternative vaccine adjuvant.作为一种替代疫苗佐剂的钴氧化物纳米粒子的佐剂活性和毒性。
Nanomedicine (Lond). 2012 Oct;7(10):1495-505. doi: 10.2217/nnm.12.35. Epub 2012 Jul 20.

引用本文的文献

1
Antigen-Dependent Adjuvanticity of Poly(lactic-co-glycolic acid)-polyethylene Glycol 25% Nanoparticles for Enhanced Vaccine Efficacy.聚乳酸-乙醇酸共聚物-聚乙二醇25%纳米颗粒的抗原依赖性佐剂活性以增强疫苗效力
Vaccines (Basel). 2025 Mar 16;13(3):317. doi: 10.3390/vaccines13030317.
2
Advancements in nanoparticle-based vaccine development against Japanese encephalitis virus: a systematic review.基于纳米颗粒的日本脑炎病毒疫苗研发进展:一项系统综述
Front Immunol. 2024 Dec 20;15:1505612. doi: 10.3389/fimmu.2024.1505612. eCollection 2024.

本文引用的文献

1
Steering DNA Condensation on Engineered Nanointerfaces.在工程化纳米界面上引导 DNA 凝聚。
Nano Lett. 2022 Nov 9;22(21):8550-8558. doi: 10.1021/acs.nanolett.2c03051. Epub 2022 Oct 31.
2
Designing spatial and temporal control of vaccine responses.设计疫苗反应的时空控制。
Nat Rev Mater. 2022;7(3):174-195. doi: 10.1038/s41578-021-00372-2. Epub 2021 Sep 28.
3
Biomimetic versus sintered macroporous calcium phosphate scaffolds enhanced bone regeneration and human mesenchymal stromal cell engraftment in calvarial defects.
仿生与烧结大孔磷酸钙支架增强颅骨缺损中的骨再生和人骨髓间充质基质细胞植入。
Acta Biomater. 2021 Nov;135:689-704. doi: 10.1016/j.actbio.2021.09.007. Epub 2021 Sep 12.
4
mRNA vaccines for infectious diseases: principles, delivery and clinical translation.传染病的 mRNA 疫苗:原理、传递和临床转化。
Nat Rev Drug Discov. 2021 Nov;20(11):817-838. doi: 10.1038/s41573-021-00283-5. Epub 2021 Aug 25.
5
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity.脂质纳米颗粒大小对 mRNA 疫苗免疫原性的影响。
J Control Release. 2021 Jul 10;335:237-246. doi: 10.1016/j.jconrel.2021.05.021. Epub 2021 May 18.
6
Design and application of nanoparticles as vaccine adjuvants against human corona virus infection.纳米颗粒作为抗人类冠状病毒感染疫苗佐剂的设计与应用。
J Inorg Biochem. 2021 Jun;219:111454. doi: 10.1016/j.jinorgbio.2021.111454. Epub 2021 Mar 29.
7
Protective CD8 T-cell response against Hantaan virus infection induced by immunization with designed linear multi-epitope peptides in HLA-A2.1/K transgenic mice.设计的线性多表位肽免疫 HLA-A2.1/K 转基因小鼠诱导针对汉坦病毒感染的保护性 CD8 T 细胞应答。
Virol J. 2020 Oct 7;17(1):146. doi: 10.1186/s12985-020-01421-y.
8
Nanoparticles as Adjuvants in Vaccine Delivery.纳米颗粒作为疫苗传递中的佐剂。
Crit Rev Ther Drug Carrier Syst. 2020;37(2):183-204. doi: 10.1615/CritRevTherDrugCarrierSyst.2020033273.
9
Fundamental insights in PLGA degradation from thin film studies.从薄膜研究看 PLGA 的降解基础认识。
J Control Release. 2020 Mar 10;319:276-284. doi: 10.1016/j.jconrel.2019.12.044. Epub 2019 Dec 27.
10
Nanoparticles and Vaccine Development.纳米颗粒与疫苗研发
Pharm Nanotechnol. 2020;8(1):6-21. doi: 10.2174/2211738507666191024162042.